The overall cancer death rate in the US has seen a significant decline, particularly among younger patients, yet disparities remain for certain cancers. While advancements in immuno-oncology are promising, the skepticism surrounding the immune system's role in cancer treatment has shifted over the years, leading to a renewed focus on innovative therapies. Despite progress, some cancers continue to show increasing mortality rates, highlighting the uneven landscape of cancer treatment advancements.
